ReP USP - Resultado da busca

Artigo de periodico
Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome (2022)
Guido, Maria Carolina ; Lopes, Natalia de Menezes ; Albuquerque, Camila Inagaki ; Tavares, Elaine Rufo ; Jensen, Leonardo; Carvalho, Priscila de Oliveira; Tavoni, Thauany Martins ; Dias, Ricardo Ribeiro; Pereira, Lygia da Veiga ; Laurindo, Francisco Rafael Martins; Maranhão, Raul Cavalcante
Source: Frontiers in Cardiovascular Medicine. Unidades: FM, FCF
Subjects: ADENOSINA, NANOPARTÍCULAS, INFLAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Frontiers in Cardiovascular Medicine, v. 9, p. 1-13 art. 893774, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcvm.2022.893774. Acesso em: 02 nov. 2024.
APA
Guido, M. C., Lopes, N. de M., Albuquerque, C. I., Tavares, E. R., Jensen, L., Carvalho, P. de O., et al. (2022). Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Frontiers in Cardiovascular Medicine, 9, 1-13 art. 893774. doi:10.3389/fcvm.2022.893774
NLM
Guido MC, Lopes N de M, Albuquerque CI, Tavares ER, Jensen L, Carvalho P de O, Tavoni TM, Dias RR, Pereira L da V, Laurindo FRM, Maranhão RC. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome [Internet]. Frontiers in Cardiovascular Medicine. 2022 ; 9 1-13 art. 893774.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fcvm.2022.893774
Vancouver
Guido MC, Lopes N de M, Albuquerque CI, Tavares ER, Jensen L, Carvalho P de O, Tavoni TM, Dias RR, Pereira L da V, Laurindo FRM, Maranhão RC. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome [Internet]. Frontiers in Cardiovascular Medicine. 2022 ; 9 1-13 art. 893774.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fcvm.2022.893774
Artigo de periodico
Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione (2021)
Garcia, Giani Martins; Roy, Jérôme; Pitta, Ivan R; Abdalla, Dulcinéia Saes Parra ; Guimarães, Andrea Grabe ; Mosqueira, Vanessa Carla Furtado ; Richard, Sylvain
Source: Pharmaceutics. Unidade: FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE, SÍNDROME X METABÓLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, v. 13, p. 1-13 art. 1521, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13091521. Acesso em: 02 nov. 2024.
APA
Garcia, G. M., Roy, J., Pitta, I. R., Abdalla, D. S. P., Guimarães, A. G., Mosqueira, V. C. F., & Richard, S. (2021). Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, 13, 1-13 art. 1521. doi:10.3390/pharmaceutics13091521
NLM
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Vancouver
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Artigo de periodico
Supramolecular cationic assemblies against multidrug-resistant microorganisms: activity and mechanism of action (2015)
Carrasco, Letícia Dias de Melo; Sampaio, Jorge Luiz Mello ; Carmona-Ribeiro, Ana Maria
Source: International Journal of Molecular Sciences. Unidades: FCF, IQ
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRASCO, Letícia Dias de Melo e SAMPAIO, Jorge Luiz Mello e CARMONA-RIBEIRO, Ana Maria. Supramolecular cationic assemblies against multidrug-resistant microorganisms: activity and mechanism of action. International Journal of Molecular Sciences, v. 16, n. 3, p. 6337-6352, 2015Tradução . . Disponível em: https://doi.org/10.3390/ijms16036337. Acesso em: 02 nov. 2024.
APA
Carrasco, L. D. de M., Sampaio, J. L. M., & Carmona-Ribeiro, A. M. (2015). Supramolecular cationic assemblies against multidrug-resistant microorganisms: activity and mechanism of action. International Journal of Molecular Sciences, 16( 3), 6337-6352. doi:10.3390/ijms16036337
NLM
Carrasco LD de M, Sampaio JLM, Carmona-Ribeiro AM. Supramolecular cationic assemblies against multidrug-resistant microorganisms: activity and mechanism of action [Internet]. International Journal of Molecular Sciences. 2015 ; 16( 3): 6337-6352.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms16036337
Vancouver
Carrasco LD de M, Sampaio JLM, Carmona-Ribeiro AM. Supramolecular cationic assemblies against multidrug-resistant microorganisms: activity and mechanism of action [Internet]. International Journal of Molecular Sciences. 2015 ; 16( 3): 6337-6352.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms16036337
Artigo de periodico
Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix (2011)
Oliveira, Maria D. L; Abdalla, Dulcinéia Saes Parra ; Guilherme, Daniel Ferreira; Faulin, Tanize do Espírito Santo; Andrade, Cesar A. S
Source: Sensors and Actuators B: Chemical. Unidades: FCF, HU
Subjects: ANTICORPOS MONOCLONAIS, LIPOPROTEÍNAS LDL, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Maria D. L et al. Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix. Sensors and Actuators B: Chemical, v. 155, n. 2, p. 775-781, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.snb.2011.01.046. Acesso em: 02 nov. 2024.
APA
Oliveira, M. D. L., Abdalla, D. S. P., Guilherme, D. F., Faulin, T. do E. S., & Andrade, C. A. S. (2011). Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix. Sensors and Actuators B: Chemical, 155( 2), 775-781. doi:10.1016/j.snb.2011.01.046
NLM
Oliveira MDL, Abdalla DSP, Guilherme DF, Faulin T do ES, Andrade CAS. Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix [Internet]. Sensors and Actuators B: Chemical. 2011 ; 155( 2): 775-781.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.snb.2011.01.046
Vancouver
Oliveira MDL, Abdalla DSP, Guilherme DF, Faulin T do ES, Andrade CAS. Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix [Internet]. Sensors and Actuators B: Chemical. 2011 ; 155( 2): 775-781.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.snb.2011.01.046

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies